| 2025-12-01 |
详情>>
内部人交易：
BIDDISCOMBE SIMON等共交易6笔
|
| 2025-11-12 |
详情>>
股本变动：
变动后总股本30539.73万股
|
| 2025-11-12 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.22美元,归母净利润-5722.5万美元,同比去年增长12.98%
|
| 2025-11-11 |
财报披露：
美东时间 2025-11-11 盘后发布财报
|
| 2025-08-08 |
详情>>
业绩披露：
2025年中报每股收益-0.18美元,归母净利润-4300.8万美元,同比去年增长14.40%
|
| 2025-05-12 |
详情>>
业绩披露：
2025年一季报每股收益-0.12美元,归母净利润-2877.9万美元,同比去年增长-9.37%
|
| 2025-04-28 |
股东大会：
将于2025-06-06召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the accompanying proxy statement to serve until the next annual meeting;
2.To approve an amendment to our Certificate of Incorporation increasing our authorized shares of common stock from 310,000,000 shares to 510,000,000 shares;
3.To approve an amendment to the 2022 MicroVision, Inc. Equity Incentive Plan;
4.To approve on a non-binding advisory basis the compensation of the company’s named executive officers;
5.To ratify the appointment of Moss Adams LLP as our independent registered public accounting firm for the current fiscal year;
6.To transact any other business properly presented at the meeting.
|
| 2025-03-26 |
详情>>
业绩披露：
2022年年报每股收益-0.32美元,归母净利润-5309.1万美元,同比去年增长-22.9%
|
| 2025-03-26 |
详情>>
业绩披露：
2024年年报每股收益-0.46美元,归母净利润-9691.5万美元,同比去年增长-16.99%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.32美元,归母净利润-6576万美元,同比去年增长-4.21%
|
| 2024-08-08 |
详情>>
业绩披露：
2023年中报每股收益-0.23美元,归母净利润-3963.6万美元,同比去年增长-48.09%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-0.25美元,归母净利润-5024.3万美元,同比去年增长-26.76%
|
| 2024-05-10 |
详情>>
业绩披露：
2024年一季报每股收益-0.13美元,归母净利润-2631.3万美元,同比去年增长-38.29%
|
| 2024-04-29 |
股东大会：
将于2024-06-05召开股东大会
会议内容 ▼▲
- 1.To elect the eight director nominees named in the accompanying proxy statement to serve until the next annual meeting;
2.To conduct an advisory vote on executive compensation;
3.To ratify the appointment of Moss Adams LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
4.To transact any other business properly presented at the meeting.
|
| 2024-02-29 |
详情>>
业绩披露：
2023年年报每股收益-0.45美元,归母净利润-8284.2万美元,同比去年增长-56.04%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.35美元,归母净利润-6310.5万美元,同比去年增长-59.29%
|
| 2023-04-05 |
股东大会：
将于2023-05-17召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the accompanying proxy statement to serve until the next annual meeting;
2.To approve an amendment to our Certificate of Incorporation increasing our authorized shares of common stock from 210,000,000 shares to 310,000,000 shares;
3.To conduct an advisory vote on executive compensation;
4.To ratify the appointment of Moss Adams LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
5.To conduct an advisory vote on the frequency of future advisory votes on executive compensation;
6.To transact any other business properly presented at the meeting.
|
| 2022-04-19 |
股东大会：
将于2022-06-01召开股东大会
会议内容 ▼▲
- 1.To elect the eight director nominees named in the accompanying proxy statement to serve until the next annual meeting;
2.To approve the 2022 MicroVision Equity Incentive Plan;
3.To conduct an advisory vote on executive compensation;
4.To ratify the appointment of Moss Adams LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
5.To transact any other business properly presented at the meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-07 |
股东大会：
将于2021-05-26召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the accompanying proxy statement to serve until the next annual meeting;
2.To approve the proposed amendment to the 2020 MicroVision, Inc. Incentive Plan;
3.To ratify the selection of Moss Adams LLP as the Company’s independent registered public accounting firm for the current fiscal year;
4.To hold a non-binding advisory vote on the compensation of the Company’s named executive officers;
5.To conduct any other business that may properly come before the meeting and any adjournment or postponement of the Annual Meeting.
|
| 2020-08-25 |
股东大会：
将于2020-10-08召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to increase the total number of shares of the Company’s authorized common stock;
2.To approve the adjournment of the Special Meeting, if necessary to solicit additional proxies, in the event that there are not sufficient votes at the time of the Special Meeting to approve Proposal 1;
3.To transact such other business as may properly come before the Special Meeting, or any adjournment(s) or postponement(s) thereof.
|
| 2020-04-03 |
股东大会：
将于2020-05-19召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the accompanying proxy statement to serve until the next annual meeting
2.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”) to amend the total number of shares of the Company’s authorized common stock;
3.To approve an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock
4.To approve the 2020 MicroVision, Inc. Incentive Plan;
5.To ratify the selection of Moss Adams LLP as the Company’s independent registered public accounting firm for the current fiscal year
6.To hold a non-binding advisory vote on the compensation of the Company’s named executive officers
7.To conduct any other business that may properly come before the meeting and any adjournment or postponement of the meeting.
|
| 2019-04-09 |
股东大会：
将于2019-05-22召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the accompanying proxy statement to serve until the next annual meeting;
2.To approve an amendment to the 2013 MicroVision, Inc. Incentive Plan;
3.To ratify the selection of Moss Adams LLP as the Company’s independent registered public accounting firm for the current fiscal year;
4.To hold a non-binding advisory vote on the compensation of the Company’s named executive officers;
5.To conduct any other business that may properly come before the meeting and any adjournment or postponement of the meeting.
|
| 2018-04-20 |
股东大会：
将于2018-06-05召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the accompanying proxy statement to serve until the next annual meeting;
2.To approve an amendment to the 2013 MicroVision, Inc. Incentive Plan;
3.To approve an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of common stock;
4.To ratify the selection of Moss Adams LLP as the Company’s independent registered public accounting firm for the current fiscal year;
5.To hold a non-binding advisory vote on the compensation of the Company’s named executive officers;
6.To conduct any other business that may properly come before the meeting and any adjournment or postponement of the meeting.
|
| 2017-04-24 |
股东大会：
将于2017-06-07召开股东大会
会议内容 ▼▲
- 1. To elect seven directors to serve until the next annual meeting;
2. To approve an amendment to the 2013 MicroVision, Inc. Incentive Plan;
3. To ratify the selection of Moss Adams LLP as the Company’s independent registered public accounting firm for the current fiscal year;
4. To hold a non-binding advisory vote on the compensation of the Company’s named executive officers;
5. To hold a non-binding advisory vote on the frequency of future executive compensation votes;
6. To conduct any other business that may properly come before the meeting and any adjournment or postponement of the meeting.
|
| 2016-04-18 |
股东大会：
将于2016-06-01召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the next annual meeting;
2.To approve an amendment to the 2013 MicroVision, Inc. Incentive Plan;
3.To ratify the selection of Moss Adams LLP as the Company’s independent registered public accounting firm for the current fiscal year;
4.To conduct any other business that may properly come before the meeting and any adjournment or postponement of the meeting.
|